Active	Status	Sponsor type	Region	Phase	Filter
6 Active 5 Inactive 11 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Yatham, Lakshmi
SMART-BD, NCT06433635: Sequential Multiple Assignment Randomized Trial for Bipolar Depression	Not yet recruiting	4	2726	Canada, US	Cariprazine, Vraylar, Aripiprazole/Escitalopram combination, Abilify/ Lexapro, Quetiapine, Seroquel, Lurasidone, Latuda	Massachusetts General Hospital, Patient-Centered Outcomes Research Institute	Bipolar I Disorder, Depression	02/30	02/30
ELICE_BD, NCT02731612: Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients	Recruiting	3	150	Europe, Canada, Japan, US	lurasidone, Latuda, Placebo	Nazlin Walji	Bipolar Disorder	12/24	03/25
CARPZ-01, NCT04771299: Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar Patients	Terminated	3	1	Canada	Cariprazine, VRAYLAR®, Placebo	Lakshmi N Yatham	Bipolar I Disorder, Cognitive Impairment	09/24	09/24
CBD-BD, NCT05867849: Cannabidiol for Bipolar Depression	Recruiting	3	360	Canada	Cannabidiol, CBD, Placebo	University of British Columbia	Bipolar Disorder	12/29	12/30
Basivireddy, Jayasree
ELICE_BD, NCT02731612: Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients	Recruiting	3	150	Europe, Canada, Japan, US	lurasidone, Latuda, Placebo	Nazlin Walji	Bipolar Disorder	12/24	03/25
CARPZ-01, NCT04771299: Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar Patients	Terminated	3	1	Canada	Cariprazine, VRAYLAR®, Placebo	Lakshmi N Yatham	Bipolar I Disorder, Cognitive Impairment	09/24	09/24